Skip to content
Search

Latest Stories

RPS: Pharmacies can play vital role in tackling AMR threats

In response to a Scottish parliamentary debate last week on Antimicrobial Resistance (AMR), the Royal Pharmaceutical Society (RPS) has explained how pharmacy can play a vital role in reducing the harms and deaths from AMR.


Scientists have predicted AMR to be the leading cause of death worldwide by 2050, resulting in 10 million deaths every year.

AMR has the potential to nullify over 100 years of modern medicine, rendering antibiotics that treat life threatening illnesses such as pneumonia, meningitis and TB far less effective, and potentially completely ineffective. In addition, common surgeries, such as hip operations and caesarean sections, could become life threatening procedures.

“There are many things that we can all do – the public, patients and health professionals – to tackle AMR,” said RPS.

RPS suggests:

  • Pharmacists can help reduce AMR by providing information to the public about how to manage common self-limiting infections which do not require an antibiotic, about when to seek further help if the condition does not resolve and about when antibiotics are needed. This will help reduce inappropriate, harmful and unnecessary use of antibiotics.
  • They can develop guidelines to ensure infections are treated with the most appropriate antibiotics, at the right dose and for the correct length of time. Prescribing antibiotics according to guidelines and giving advice to patients about how to take antibiotics safely.
  • Pharmacies can encourage the public to return any unused medicines, including antibiotics, to pharmacies for safe disposal.
  • A clear link exists between antibiotics getting into the environment and the development of AMR. This is why it is crucial that medicines are disposed of safely and never flushed down a toilet or sink, or put into household rubbish. RPS has produced an environmental sustainability policy which includes a section on reducing AMR through tackling pollution by pharmaceutical waste.

Commenting on the debate held on 21 April at the Scottish Parliament, Director for Scotland at RPS, Clare Morrison said: “Antimicrobial resistance is a real threat which has the potential to devastate human health. Thankfully, there are concrete actions we can take right now to tackle this. But we all need to act now.

“As experts in medicines, pharmacists have a unique role to play in advising the public and healthcare professionals about actions to limit the effects of antimicrobial resistance. These include providing advice on: managing self-limiting conditions without using antibiotics, prescribing antibiotics appropriately and on the importance of returning any unused medicines to pharmacies for safe disposal.”

More For You

Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Keep ReadingShow less
NHS expands pharmacogenomics trial to enhance personalised medicine
The NHS is poised to take a bold step towards personalised medicine (gettyimages)

Personalised medicine: NHS expands pharmacogenomics trial across England

With this study, the NHS aims to address barriers to the national implementation of pharmacogenomics, making personalised medicine to become standard practice

A national pharmacogenomics research study is making significant progress towards adopting personalised medicine within the NHS.

Keep ReadingShow less
Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use
The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety (gettyimages)

Clinical pharmacists in GP practices improve prescribing quality, patient safety

Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use

The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety in primary care settings, a new study has revealed.

Keep ReadingShow less
India aims to become a top five pharma exporter by 2047
India is the world’s largest supplier of generic medicines (gettyimages)

India’s pharma exports expected to cross £280 billion by 2047

India aims to become a top five pharma exporter by expanding into specialty generics, biosimilars and innovative products

India’s pharmaceutical exports are projected to grow from $27 billion (£21.73 billion) in 2023 to $65 billion (£ 52.31 billion) by 2030, with the potential to reach an estimated $350 billion (£281.72 billion) by 2047, according to a new industry report.

Keep ReadingShow less